Bids Are Invited For Psd - Nitric Oxide Therapy Serv For Hblt

In Order To Fulfill Its Healthcare Purpose, The Barros Luco Trudeau Hospital, A Self-Managed Network Establishment, Requires The Contracting Of Nitric Oxide Inhalation Therapy For Its Neonatology Service And To Comply With The Auge Clinical Guide Established By The Ministry Of Health. Where The Use Of This Therapy Is Indicated For Patients With Respiratory Distress Syndrome Rds Of The Newborn. This Therapy Is Indicated For The Treatment Of Newborns Of 34 Weeks Of Gestation Or More, With A Diagnosis Of Hypoxic Respiratory Failure Associated With Clinical Or Echocardiographic Evidence Of Pulmonary Hypertension. This Treatment Has An Impact On Reducing Mortality Associated With This Pathology, Less Connection To Ecmo And Reduction Of Respiratory Sequelae, In Addition To Contributing To Improving The Quality Of Life Of Children Who Leave The Neonatology Unit. Its Main Action Is To Act As A Strong Selective Vasodilator Of The Pulmonary Territory That Improves Oxygenation In Seriously Ill Patients With A Very Altered Oxygenation Index. The Diagnosis Of The Use Of Nitric Oxide Is Established For Newborn Respiratory Distress Syndrome Associated With Pph Persistent Pulmonary Hypertension Such As Bronchopneumonia, Diaphragmatic Hernia, Meconium Aspiration, Which Occurs In The First Days Of Life, Even In The First Hours , Nitric Oxide Therapy Is Prescribed For Neonates Up To 28 Days Of Age. Notwithstanding This, There May Be Exceptions Where The Use Of Nitric Oxide Is Necessary After One Week Of Life, Associated With Bronchopneumonia Or Shock Associated With Pulmonary Hypertension.